Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MD2-Toll-like Receptor 4 (MD2-TLR4) complex is a cell surface receptor essential for innate immune recognition of bacterial lipopolysaccharide (LPS). It plays a pivotal role in the host's defense against Gram-negative bacteria, initiating inflammatory responses upon LPS binding. The complex consists of MD-2, a secreted protein, and TLR4, a pattern recognition receptor. Activation leads to downstream signaling cascades resulting in activation of NF-kB and production of pro-inflammatory cytokines. Targeting this complex is of therapeutic interest for modulating inflammatory diseases and sepsis.
Ligand binding to the MD2-TLR4 complex induces dimerization and downstream signaling cascades (MyD88-dependent and TRIF-dependent) leading to NF-kB activation and cytokine production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MD2-Toll-like Receptor 4 Complex (MD2-TLR4 Complex).